David Nanchen

Summary

Affiliation: Leiden University Medical Center
Country: The Netherlands

Publications

  1. ncbi Public health impact of statin prescribing strategies based on JUPITER
    David Nanchen
    Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland
    Prev Med 52:159-63. 2011
  2. ncbi Cardiovascular risk estimation and eligibility for statins in primary prevention comparing different strategies
    David Nanchen
    Department of Ambulatory Care and Community Medicine, University Hospital Centre, University of Lausanne, Switzerland
    Am J Cardiol 103:1089-95. 2009
  3. ncbi Statins for cardiovascular prevention according to different strategies: a cost analysis
    Marcia K Ito
    Institute of Health Economics and Management, University of Lausanne, Lausanne, Switzerland
    Am J Cardiovasc Drugs 11:33-44. 2011
  4. ncbi Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts
    Baris Gencer
    Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland
    Circulation 126:1040-9. 2012
  5. ncbi Mortality associated with diabetes and cardiovascular disease in older women
    David Nanchen
    Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland
    PLoS ONE 7:e48818. 2012
  6. ncbi Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality
    Nicolas Ochs
    University of Lausanne, Lausanne, Switzerland
    Ann Intern Med 148:832-45. 2008

Collaborators

Detail Information

Publications6

  1. ncbi Public health impact of statin prescribing strategies based on JUPITER
    David Nanchen
    Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland
    Prev Med 52:159-63. 2011
    ..To evaluate the public health impact of statin prescribing strategies based on the Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin Study (JUPITER)...
  2. ncbi Cardiovascular risk estimation and eligibility for statins in primary prevention comparing different strategies
    David Nanchen
    Department of Ambulatory Care and Community Medicine, University Hospital Centre, University of Lausanne, Switzerland
    Am J Cardiol 103:1089-95. 2009
    ..Following the International Atherosclerosis Society and the Adult Treatment Panel III recommendations might prevent more CHD deaths at the cost of higher numbers needed to treat compared with European Society of Cardiology guidelines...
  3. ncbi Statins for cardiovascular prevention according to different strategies: a cost analysis
    Marcia K Ito
    Institute of Health Economics and Management, University of Lausanne, Lausanne, Switzerland
    Am J Cardiovasc Drugs 11:33-44. 2011
    ..However, the cost effectiveness of statin treatment in the primary prevention of CHD has not been fully established...
  4. ncbi Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts
    Baris Gencer
    Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland
    Circulation 126:1040-9. 2012
    ..Limited prospective data exist on the association between subclinical thyroid dysfunction and heart failure events...
  5. ncbi Mortality associated with diabetes and cardiovascular disease in older women
    David Nanchen
    Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland
    PLoS ONE 7:e48818. 2012
    ..We aimed to assess whether diabetes was associated with a similar risk of total and cause-specific mortality as a history of CVD in older women...
  6. ncbi Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality
    Nicolas Ochs
    University of Lausanne, Lausanne, Switzerland
    Ann Intern Med 148:832-45. 2008
    ..Data on the association between subclinical thyroid dysfunction and coronary heart disease (CHD) and mortality are conflicting...